Carroll Financial Associates’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | $18.1M | Sell |
290,799
-897
| -0.3% | -$55.8K | 0.96% | 19 |
|
|
2021
Q3 | $21.8M | Buy |
291,696
+3,942
| +1% | +$295K | 1.22% | 18 |
|
|
2021
Q2 | $26.6M | Buy |
287,754
+5,197
| +2% | +$481K | 1.51% | 16 |
|
|
2021
Q1 | $25.1M | Sell |
282,557
-83,738
| -23% | -$7.43M | 1.54% | 15 |
|
|
2020
Q4 | $34.2M | Sell |
366,295
-83,265
| -19% | -$7.77M | 2.27% | 10 |
|
|
2020
Q3 | $28.6M | Sell |
449,560
-22,436
| -5% | -$1.43M | 2.21% | 10 |
|
|
2020
Q2 | $24.6M | Buy |
471,996
+320
| +0.1% | +$16.7K | 2.05% | 9 |
|
|
2020
Q1 | $14.8M | Buy |
471,676
+24,149
| +5% | +$755K | 1.45% | 15 |
|
|
2019
Q4 | $15M | Buy |
447,527
+95,886
| +27% | +$3.21M | 1.19% | 15 |
|
|
2019
Q3 | $10.4M | Sell |
351,641
-577
| -0.2% | -$17K | 0.91% | 17 |
|
|
2019
Q2 | $12.1M | Buy |
352,218
+2,560
| +0.7% | +$88.2K | 1.06% | 16 |
|
|
2019
Q1 | $11.5M | Buy |
349,658
+215,979
| +162% | +$7.1M | 1.08% | 18 |
|
|
2018
Q4 | $3.65M | Buy |
133,679
+97,784
| +272% | +$2.67M | 0.41% | 37 |
|
|
2018
Q3 | $1.2M | Sell |
35,895
-1,167
| -3% | -$39K | 0.13% | 108 |
|
|
2018
Q2 | $1.08M | Buy |
37,062
+6,560
| +22% | +$191K | 0.11% | 111 |
|
|
2018
Q1 | $785K | Buy |
30,502
+3,072
| +11% | +$79.1K | 0.09% | 126 |
|
|
2017
Q4 | $671K | Buy |
27,430
+11,950
| +77% | +$292K | 0.07% | 138 |
|
|
2017
Q3 | $415K | Sell |
15,480
-3,870
| -20% | -$104K | 0.05% | 177 |
|
|
2017
Q2 | $433K | Buy |
+19,350
| New | +$433K | 0.05% | 176 |
|